Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Immuron Limited ( (AU:IMC) ) is now available.
Immuron Limited has announced the issuance of 1,133,840 ordinary shares without disclosure under Part 6D.2 of the Corporations Act. The company confirms compliance with relevant provisions of the Corporations Act and states there is no excluded information requiring disclosure, indicating a transparent operational stance.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of gut-mediated diseases.
YTD Price Performance: 1.27%
Average Trading Volume: 203,461
Technical Sentiment Signal: Hold
Current Market Cap: A$21.46M
Find detailed analytics on IMC stock on TipRanks’ Stock Analysis page.